Cargando…

Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?

Detalles Bibliográficos
Autor principal:	Hasselbalch, Hans C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306306/ https://www.ncbi.nlm.nih.gov/pubmed/32647805 http://dx.doi.org/10.1097/HS9.0000000000000407

Ejemplares similares

Correction Notice: Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?
Publicado: (2020)

MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
por: Hasselbalch, Hans Carl, et al.
Publicado: (2015)

A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon‐alpha2
por: Dam, Marc J. B., et al.
Publicado: (2022)

Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation
por: Liisborg, Charlotte, et al.
Publicado: (2021)

Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
por: Andersen, Morten, et al.
Publicado: (2017)

Biology and therapeutic targeting of molecular mechanisms in MPNs
por: How, Joan, et al.
Publicado: (2023)

Predictive Value of Kozak Gene Polymorphism for Thrombosis in Patients with Philadelphia-Negative MPNs
por: El-Ghonemy, Mohamed Sabry, et al.
Publicado: (2021)

A tale of two alleles: TP53 and transformation in MPNs
por: Brierley, Charlotte, et al.
Publicado: (2022)

Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
por: Skov, Vibe
Publicado: (2020)

Magnetic Peripheral Nerve Stimulation (mPNS) for Chronic Pain
por: Bedder, Marshall, et al.
Publicado: (2023)

Mathematical Modeling of MPNs Offers Understanding and Decision Support for Personalized Treatment
por: Ottesen, Johnny T., et al.
Publicado: (2020)

Recent Advances of Fe(III)/Fe(II)-MPNs in Biomedical Applications
por: Chen, Weipeng, et al.
Publicado: (2023)

A JAK of all trades: how global phosphoproteomics reveal the Achilles heel of MPNs
por: Schnoeder, Tina M., et al.
Publicado: (2021)

Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark survey
por: Mesa, Ruben, et al.
Publicado: (2016)

Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports
por: Pennisi, Maria Stella, et al.
Publicado: (2023)

Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs
por: Jutzi, Jonas S., et al.
Publicado: (2022)

Measuring menstrual hygiene experience: development and validation of the Menstrual Practice Needs Scale (MPNS-36) in Soroti, Uganda
por: Hennegan, Julie, et al.
Publicado: (2020)

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey
por: Harrison, Claire N., et al.
Publicado: (2017)

Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases
por: Liu, Timothy J., et al.
Publicado: (2022)

Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: results from the living with MPNs survey
por: Yu, Jingbo, et al.
Publicado: (2018)

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
por: Hermouet, Sylvie, et al.
Publicado: (2015)

Oxygen-18 Kinetic Isotope Effects of Nonheme Iron Enzymes HEPD and MPnS Support Iron(III) Superoxide as the Hydrogen Abstraction Species
por: Zhu, Hui, et al.
Publicado: (2015)

Unlocking the Role of Endothelial MPL Receptor and JAK2V617F Mutation: Insights into Cardiovascular Dysfunction in MPNs and CHIP
por: Zhang, Haotian, et al.
Publicado: (2023)

Complementary and Alternative Medicine for Diabetes
por: Yang, Wen-Chin, et al.
Publicado: (2013)

What’s in complementary medicines?
por: Moses, Geraldine
Publicado: (2019)

Announcing the affiliation between BMC Complementary and Alternative Medicine and Cochrane Complementary Medicine
por: Wieland, L. Susan, et al.
Publicado: (2019)

Metabolomics profiling: a potential tool for predicting immunoglobulin A nephropathy progression
por: Kim, Dong Ki
Publicado: (2023)

Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient survey
por: Yu, Jingbo, et al.
Publicado: (2019)

A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs
por: Link-Lenczowska, Dorota, et al.
Publicado: (2018)

Complementary and Alternative Medicine for the Treatment of Fibromyalgia
por: Langhorst, Jost, et al.
Publicado: (2014)

Complementary and Alternative Medicine for Diabetes 2014
por: Yang, Wen-Chin, et al.
Publicado: (2015)

A 17-gene-expression profile to improve prognosis prediction in childhood acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

The Complementary and Alternative Medicine for Antithrombosis
por: Yang, Feng-Qing, et al.
Publicado: (2015)

Complementary and Alternative Medicine in Midwifery
por: Abedzadeh Kalahroudi, Masoumeh
Publicado: (2014)

Complementary and integrative interventions for PTSD
por: Niles, Barbara, et al.
Publicado: (2023)

Complementary feeding: Should baby be leading the way?
por: Langley‐Evans, Simon C.
Publicado: (2022)

miRNA profiling as a complementary diagnostic tool for amyotrophic lateral sclerosis
por: Cheng, Jack, et al.
Publicado: (2023)

The Immune System and Complementary and Alternative Medicine
por: Cooper, Edwin L.
Publicado: (2007)

Translational Research in Complementary and Alternative Medicine
por: Jia, Wei, et al.
Publicado: (2013)

Complementary and Alternative Medicine and Cancer Survivorship
por: Huntley, Alyson L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i6h6m5v5ckvdcsovk0m2fhdrum